Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:16 pm Sale | 2021-12-31 | 13G | Atreca, Inc. BCEL | EcoR1 Capital, LLC | 0 0.000% | -2,426,685 (Position Closed) | Filing History |
| 2022-02-14 2:15 pm Unchanged | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital, LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:15 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital, LLC | 253,897 1.700% | -111,111 (-30.44%) | Filing History |
| 2022-02-14 1:39 pm Purchase | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | EcoR1 Capital, LLC | 6,319,232 9.300% | 1,384,300 (+28.05%) | Filing History |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | EcoR1 Capital, LLC | 1,060,010 3.000% | -1,473,625 (-58.16%) | Filing History |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | EcoR1 Capital, LLC | 0 0.000% | -4,368,500 (Position Closed) | Filing History |
| 2022-02-14 1:37 pm Sale | 2021-12-31 | 13G | AC Immune S.A. ACIU | EcoR1 Capital, LLC | 749,585 0.900% | -3,952,575 (-84.06%) | Filing History |
| 2022-02-14 12:49 pm Purchase | 2021-12-31 | 13G | Xencor, Inc. XNCR | EcoR1 Capital, LLC | 4,906,106 8.400% | 359,034 (+7.90%) | Filing History |
| 2022-02-02 7:52 pm Purchase | 2022-01-27 | 13G | Galapagos N.V. GLPG | EcoR1 Capital, LLC | 3,407,246 5.200% | 3,407,246 (New Position) | Filing History |
| 2022-01-31 4:39 pm Purchase | 2022-01-21 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 4,543,447 6.800% | 2,770,410 (+156.25%) | Filing History |
| 2022-01-13 6:45 pm Purchase | 2022-01-12 | 13D | Prothena Corporation plc PRTA | EcoR1 Capital, LLC | 11,584,280 24.900% | 2,157,640 (+22.89%) | Filing History |
| 2021-12-10 5:24 pm Sale | 2021-12-10 | 13G | Odonate Therapeutics, Inc. ODTC | EcoR1 Capital, LLC | 0 0.000% | -0 (Position Closed) | Filing History |
| 2021-12-10 5:08 pm Purchase | 2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 5,376,134 6.500% | 5,376,134 (New Position) | Filing History |
| 2021-11-18 1:03 pm Purchase | 2021-11-17 | 13G | Odonate Therapeutics, Inc. ODTC | EcoR1 Capital, LLC | 0 14.800% | 0 (+69.51%) | Filing History |
| 2021-11-16 12:20 pm Purchase | 2021-11-05 | 13G | 2seventy bio, Inc. TSVT | EcoR1 Capital, LLC | 1,890,663 8.100% | 1,890,663 (New Position) | Filing History |
| 2021-10-22 4:46 pm Purchase | 2021-10-12 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital, LLC | 3,557,507 9.400% | 3,557,507 (New Position) | Filing History |
| 2021-10-05 1:03 pm Sale | 2021-09-30 | 13G | Corvus Pharmaceuticals, Inc. CRVS | EcoR1 Capital, LLC | 81,077 0.200% | -5,000,000 (-98.40%) | Filing History |
| 2021-09-23 3:14 pm Purchase | 2021-09-22 | 13G | Corvus Pharmaceuticals, Inc. CRVS | EcoR1 Capital, LLC | 5,081,077 12.000% | 1,501,700 (+41.95%) | Filing History |
| 2021-07-19 5:23 pm Purchase | 2021-07-08 | 13G | Odonate Therapeutics, Inc. ODTC | EcoR1 Capital, LLC | 0 8.700% | 0 (New Position) | Filing History |
| 2021-07-19 5:16 pm Purchase | 2021-07-09 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 4,572,047 6.400% | 4,572,047 (New Position) | Filing History |